IMMUNOSENESCENCE IS A FACTOR IN RESPONSE TO INFLIXIMAB THERAPY IN IBD PATIENTS OVER 65 YEARS OF AGE
Mary Hussey 1
Jayne Doherty 1
Yvonne Bailey 1
David Kevans 1
Deirdre McNamara 1
1 TAGG Research Centre, School of Medicine, Trinity College, Dublin, Ireland
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]